Effect of beta2‐adrenergic agonist and resistance training on maximal oxygen uptake and muscle oxidative enzymes in men

Effect of beta2‐adrenergic agonist and resistance training on maximal oxygen uptake and muscle oxidative enzymes in men / Anders Krogh Lemminger, Søren Jessen, Sajad Habib, Johan Onslev, Stella Feng Sheng Xu, Vibeke Backer, Jens Bangsbo, Morten Hostrup. - (Scandinavian journal of medicine & science in sports (2019) 23 Aug; p. 1-30).
- PMID: 31442335.
- DOI: 10.1111/sms.13544


Abstract

While beta2-adrenoceptor stimulation has been shown to increase lean mass and to alter metabolic properties of skeletal muscle, adaptations in muscle oxidative enzymes and maximal oxygen uptake (V̇O2max) in response to beta2-adrenergic agonist treatment are inadequately explored in humans, particularly in association with resistance training. Herein we investigated beta2-adrenergic-induced changes in V̇O2max, leg and arm composition, and muscle content of oxidative enzymes in response to treatment with the selective beta2-adrenergic agonist terbutaline with and without concurrent resistance training in young men. Forty-six subjects were randomized to four weeks of lifestyle maintenance (n=23) or resistance training (n=23). Within the lifestyle maintenance and resistance training group, subjects received daily terbutaline (8·0.5 mg)(n=13) or placebo (n=10) treatment. No apparent treatment by training interactions were observed during the study period. Terbutaline increased leg and arm lean mass with the intervention, whereas no treatment differences were observed in absolute V̇O2max and incremental peak power output (iPPO). Treatment main effects were observed for V̇O2-reserve (P<0.05), V̇O2max relative to body mass (P<0.05), V̇O2max relative to leg lean mass (P<0.01), and iPPO relative to leg lean mass, in which terbutaline had a negative effect compared to placebo. Furthermore, content of electron transport chain complex I-V decreased by 11% (P<0.05) for terbutaline compared to placebo. Accordingly, chronic treatment with the selective beta2-adrenergic agonist terbutaline may negatively affect V̇O2max and iPPO in relative terms, but not in absolute.

Parameters

Science
Study
Date
23 August 2019
People
Backer, Vibeke
Bangsbo, Jens
Feng, Stella
Habib, Sajad
Hostrup, Morten
Jessen, Søren
Lemminger, Anders Krogh
Onslev, Johan
Xu, Sheng
Country
Denmark
Language
English
Other organisations
Bispebjerg Hospital
Københavns Universitet - University of Copenhagen (UCPH)
Københavns Universitetshospital - Copenhagen University Hospital
Doping classes
S3. Beta-2 Agonists
Substances
Terbutaline
Document category
Abstract
Date generated
1 August 2019
Date of last modification
28 August 2019
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin